-
Loading metrics
Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1
- Johannes Ettl,
- Evelyn Klein,
- Alexander Hapfelmeier,
- Kirsten Grosse Lackmann,
- Stefan Paepke,
- Christoph Petry,
- Katja Specht,
- Laura Wolff,
- Heinz Höfler,
- Marion Kiechle
x
- Published: September 6, 2017
- https://doi.org/10.1371/journal.pone.0183917